Is Silk Road Medical a Buy?
One biotech initial public offering (IPO) that piqued investors' interest last year was a stroke-prevention company that's quickly become a Wall Street darling. Silk Road Medical (NASDAQ: SILK) went public in April 2019, and despite what's been a bit of a tumultuous past few months, its stock ended January up over 25% from when it first started trading.
While the company seems to have a promising future ahead of it, nothing is guaranteed in the turbulent world of biotech. Let's take a moment and look through the company's details and see whether the stock is a good investment or not.
Image source: Getty Images.
Source Fool.com


